Not long ago I was minding my own business, living my life and everything changed. I dove head first into SSRI and what they can do.

Today I started listening to the FDA panel, I already know the outcome, as the media did their thing and tried to discredit the panel members.

I started my own research. It’s really pretty simple to find. Who knows when you will read this post as it will be buried in algorhythms of how great SSRI are for women with depression. They won’t share the potential long term affects of the knowledge that SSRI cross the placenta. They won’t share how sonograms show the brain affected in the mother, by the SSRI. If it’s affecting the mom AND it crosses to the placenta- how can we ignore the fact this is affecting the developing child, the developing fetus, the living human breathing baby. How can the “potential side affects” be ignored? There is one reason only.

More and more people are sounding the alarm and the voices are getting louder and uniting together.
Here you can learn and take a course on Pregnancy and Antidepressants.

Here are the studies so you can dig in yourself and interpret them.

• 1. SSRIs and Fetal Brain Development
  Source: Oberlander et al., Trends in Neurosciences, 2009
  Findings: SSRIs cross the placenta and alter fetal serotonin systems crucial for brain development.
  🔗 https://doi.org/10.1016/j.tins.2009.09.003
  
  2. Neonatal Adaptation Syndrome from Prenatal SSRI Use
  Source: Moses-Kolko et al., The Journal of the American Medical Association, 2005
  Findings: Infants exposed in utero showed tremors, irritability, and respiratory distress.
  🔗 https://jamanetwork.com/journals/jama/fullarticle/201429
  
  3. Congenital Heart Defects Linked to SSRIs
  Source: Alwan et al., The New England Journal of Medicine, 2007
  Findings: Paroxetine and fluoxetine in the first trimester increase septal heart defects.
  🔗 https://www.nejm.org/doi/full/10.1056/NEJMoa052744
  
  4. Impaired Fetal Head Growth from SSRI Exposure
  Source: El Marroun et al., JAMA Psychiatry, 2012
  Findings: In utero SSRI exposure is associated with reduced fetal head growth.
  🔗 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/1151023
  
  5. Persistent Pulmonary Hypertension in the Newborn (PPHN)
  Source: Chambers et al., New England Journal of Medicine, 2006
  Findings: Late-pregnancy SSRI exposure increases risk of PPHN.
  🔗 https://www.nejm.org/doi/full/10.1056/NEJMoa052744
  
  6. Preterm Birth Risk Associated with SSRIs
  Source: Oberlander et al., Archives of General Psychiatry, 2006
  Findings: SSRIs associated with increased preterm delivery risk, independent of depression severity.
  🔗 https://jamanetwork.com/journals/jamapsychiatry/fullarticle/209111
  
  7. Placental Transfer of SSRIs and Effects on Fetal Brain
  Source: Rampono et al., British Journal of Clinical Pharmacology, 2009
  Findings: SSRIs transfer through placenta and amniotic fluid, affecting fetal neurochemistry.
  🔗 https://bpspubs.onlinelibrary.wiley.com/doi/10.1111/j.1365-2125.2008.03395.x
  
  8. Altered Brain Connectivity in SSRI-Exposed Newborns
  Source: Rifkin-Graboi et al., Translational Psychiatry, 2013
  Findings: SSRI exposure linked to structural and connectivity changes in infant brain.
  🔗 https://www.nature.com/articles/tp2013115
  
  9. Increased NICU Admission in SSRI-Exposed Infants
  Source: Malm et al., Pediatrics, 2016
  Findings: Prenatal SSRIs linked to increased neonatal intensive care admissions.
  🔗 https://publications.aap.org/pediatrics/article/138/5/e20160192/52791
  
  10. Review: Neurobehavioral Outcomes of Prenatal SSRI Use
  Source: Huybrechts et al., CNS Drugs, 2013
  Findings: Behavioral and motor delays in children exposed to SSRIs.
  🔗 https://link.springer.com/article/10.1007/s40263-013-0091-7
  
  11. Rodent Models: SSRIs and Lifelong Behavioral Changes
  Source: Ansorge et al., Science, 2004
  Findings: SSRIs during development induce anxiety and depression-like behavior in rodents.
  🔗 https://www.science.org/doi/10.1126/science.1097098
  
  12. Long-Term Risks of Prenatal SSRI Exposure: Meta-Analysis
  Source: Gentile, Human Psychopharmacology: Clinical and Experimental, 2017
  Findings: Reviews all major studies; confirms risk of adaptation issues, birth outcomes, and long-term behavior.
  🔗 https://onlinelibrary.wiley.com/doi/10.1002/hup.2612